IHS (IHS) Q3 2025 earnings summary

Executive summary

• Q3 2025 results exceeded expectations, with strong revenue, Adjusted EBITDA, and ALFCF growth, and a significant rebound in net income, supporting continued deleveraging.

• Full-year 2025 outlook was raised for revenue, Adjusted EBITDA, and ALFCF, driven by robust year-to-date performance and favorable FX, especially in Nigeria and Brazil.

• Strategic focus remains on organic growth, efficiency, cash flow maximization, and disciplined capital allocation, with future shareholder returns under consideration.

• Strategic initiatives included a new site agreement in Brazil and the completed sale of Rwanda operations.

Financial highlights

• Q3 2025 revenue was $455.1 million, up 8.3% year-over-year, with constant currency growth near 9%.

• Adjusted EBITDA reached $261.5 million (57.5% margin), up over 6% year-over-year.

• Net income rebounded to $151.0 million, compared to a loss in prior quarters.

• ALFCF was $157.8 million, an 81% increase year-over-year, with a 60.4% cash conversion rate.

• CapEx was $77.3 million, up 16% year-over-year, mainly due to Nigeria and maintenance.

• Consolidated net leverage ratio reduced to 3.3x, down from 3.9x a year ago.

• Liquidity exceeded $950 million at quarter end, rising above $1 billion post-Rwanda disposal.

Outlook and guidance

• Full-year 2025 revenue guidance raised to $1.75–$1.77 billion, Adjusted EBITDA to $995–$1,015 million, and ALFCF to $400–$420 million.

• Guidance reflects strong constant currency growth, favorable FX, and organic revenue growth of about 10% at midpoint.

• CapEx guidance unchanged at $240–$270 million, assuming 600 new sites.

• Net leverage target remains at 3–4x, expected to be at the low end by year-end.

• Management expects continued revenue growth from CPI escalators, new sites, and lease amendments.